Continually Updated Clinical Reference
 
 
  All Sources     eMedicine     Medscape     Drug Reference     MEDLINE
 
eMedicine - Ankle Impingement Syndrome : Article by

Quick Find
Authors & Editors
Introduction
Clinical
Differentials
Workup
Treatment
Medication
Follow-up
Miscellaneous
References




Patient Education
Foot, Ankle, Knee, and Hip Center

Sports Injury Center

Sprains and Strains Center

Ankle Sprain Overview

Ankle Sprain Causes

Ankle Sprain Symptoms

Ankle Sprain Treatment

Sprains and Strains Overview




Author: Marc A Molis, MD, Medical Director of Urgent Care, Medical Director of Occupational Medicine and Workers Compensation, Rushford Clinic, Winona Health System

Marc A Molis is a member of the following medical societies: American Academy of Family Physicians, American Medical Association, and American Medical Society for Sports Medicine

Coauthor(s): Mark William Niedfeldt, MD, Assosiate Professor, Departments of Family and Community Medicine, Orthopaedic Surgery, Cell Biology, Neurobiology and Anatomy; Associate Director, Primary Care Sports Fellowship, Medical College of Wisconsin; Janos P Ertl, MD, Clinical Assistant Professor, Department of Orthopedic Surgery, Chief of Orthopedic Trauma, University of California at Davis; Director of Amputee Clinic, Kaiser Hospital; Gyorgy Kovacs, MD, Department of Orthopedic Surgery, Consulting Surgeon, GOC Clinic

Editors: David T Bernhardt, MD, Director of Adolescent and Sports Medicine Fellowship, Associate Professor, Department of Pediatrics, University of Wisconsin; Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine; Russell D White, MD, Professor of Medicine, Department of Community and Family Medicine, University of Missouri-Kansas City School of Medicine, Truman Medical Center Lakewood; Jon Whitehurst, MD, Consulting Staff, Rockford Orthopedic Associates; Wylie D Lowery, Jr, MD, Department of Orthopedic Surgery, Associate Professor, George Washington University

Author and Editor Disclosure

Synonyms and related keywords: impingement lesions, meniscoid lesion, synovial irritation, capsular irritation, ankle injury, inversion ankle sprain, chronic ankle pain, sports injuries, anterior talofibular ligament, ATFL, anterolateral ankle impingement, syndesmosis impingement, posterior impingement, arthroscopic excision, arthroscopic debridement

Background

Soft tissue impingement lesions of the ankle usually occur as a result of synovial or capsular irritation secondary to traumatic injuries, infection, or rheumatologic or degenerative disease states. They may also be congenital in origin. The leading causes of impingement lesions are posttraumatic injuries, usually ankle sprains, leading to chronic pain. Involved areas may include the anterolateral gutter, syndesmosis, and posterior ankle regions.

In 1950, Glassman et al reported on 9 patients presenting with chronic persistent pain and swelling around the anterolateral aspect of the ankle following an inversion ankle sprain. At the time of surgery, a massive hyalinized connective-tissue band extending from the anteroinferior region of the talofibular ligament into the ankle joint was found. They referred to this pathologic entity as a meniscoid lesion because of its resemblance to a torn meniscus of the knee. It was believed that repetitive tension on this tissue led to increasing hypertrophy and fibrosis, resulting in impingement on the talar cartilage and causing pain and swelling. Resolution of symptoms occurred in all cases with excision of the pathologic tissue.

In 1982, Waller described a pain syndrome along the anteroinferior border of the fibula and anterolateral talus following repetitive inversion injuries. Examination of his patients revealed foot pronation and heel valgus. He believed this pathology to be synovial compression or chondromalacia of the lateral talar dome and called it the anterolateral corner compression syndrome. Bassett et al found and described a separate pathologic fascicle of the anterior talofibular ligament (ATFL) in syndesmotic impingement. Following a tear of the ATFL, the anterolateral talar dome extrudes anteriorly with dorsiflexion, resulting in impingement. Hamilton described a labrum or pseudomeniscus of the posterior lip of the tibia, which can become torn or hypertrophied with ankle sprains and lead to posterior impingement.

Frequency

United States

After an ankle sprain, 20-40% of patients have chronic ankle pain; of these patients, approximately one third have pain related to impingement.

Sport Specific Biomechanics

The most common mechanism of acute injury is plantar flexion/inversion injury resulting in acute ankle sprain (eg, basketball player landing on opponent's shoe, cross-country runner stepping in a hole).



History

  • Anterolateral ankle impingement: Chronic vague pain over the anterolateral ankle occurs, usually associated with cutting and pivoting movements.


  • Syndesmosis impingement: Syndesmotic or a "high" ankle sprain occurs in up to 10% of all ankle injuries.


  • Posterior impingement: This is usually located posteriorly or posterolaterally following an ankle sprain.

Physical

  • Anterolateral ankle impingement: Tenderness is noted along the lateral gutter and ATFL.  Proprioception may be poor in these patients.


  • Syndesmosis impingement: Extreme tenderness along the syndesmosis and interosseous membrane is noted, along with pain on bimalleolar compression of syndesmosis and on passive external rotation stress of the ankle.


  • Posterior impingement: Diagnosis is often difficult, requiring a high index of clinical suspicion. Posterior impingement often causes lingering pain, swelling, and catching of a synovial nodule and may be worse with forced plantar flexion.  If further confirmation is necessary, local anesthetic can be injected around the posterior talus, and then the impingement test (reproduction of pain with passive plantarflexion of the ankle) can be performed without pain.

Causes

  • Anterolateral ankle impingement: Inversion ankle injuries and sprains sustained while playing basketball (45%), volleyball (25%), or soccer (31%) are common causes. Injury to the ligament or joint capsule may lead to synovitis, scar tissue, hypertrophied soft tissue, and, ultimately, impingement.


  • Syndesmosis impingement: Tearing of the syndesmosis or the ATFL results in chronic instability and extrusion of the anterolateral talus, leading to syndesmotic impingement. Ice hockey, football, and soccer players often sustain this type of injury.


  • Posterior impingement: Hypertrophy or tear of the posterior inferior tibiofibular ligament, transverse tibiofibular ligament, tibial slip, or pathologic labrum on the posterior ankle joint can lead to posterior impingement, which may pinch on the os trigonum or posterior talus of calcaneus.  This can also result from pathology of the os trigonum-talar process, ankle osteochondritis, flexor hallucis longus tenosynovitis, subtalar joint disease, and fracture.  Pain is caused by forced plantar flexion and push-off maneuvers, seen in dancing, kicking, gymnastics, or downhill-running types of activities (Maquirriain, 2005). In ballet dancers, forcing turnout of the foot can predispose to this condition (Brukner, 2000).



Other Problems to be Considered

Osteochondral lesions of the talus
Calcific ossicles
Peroneal subluxation
Degenerative joint disease
Tarsal coalition
Nerve entrapment (tarsal tunnel syndrome)
Occult fractures of the talus and calcaneus
Subtalar joint dysfunction
Reflex sympathetic dystrophy (complex regional pain syndrome)



Imaging Studies

  • Plain radiography, bone scanning, and CT scanning findings are usually normal.  Plain radiographs may show an enlarged posterior tubercle of the talus or an os trigonum in patients with posterior impingement. Having the paitent adopt a lunge position that reproduces their pain may show bone-on-bone impingement on a plain radiograph.


  • Approximately 30% of MRI findings are positive in persons with anterolateral ankle impingement.  The most common finding is a low-signal "meniscoid" mass in the lateral gutter of the ankle.


  • Stress radiography findings are usually negative, and this study is not indicated.



Acute Phase

Rehabilitation Program

Physical Therapy

Initial treatment includes nonsteroidal anti-inflammatory drugs (NSAIDs) as needed for pain, physical therapy, bracing, and orthotics.

Surgical Intervention

With failure of conservative modalities, surgical intervention is indicated. Arthroscopic excision and debridement is the treatment of choice.

Other Treatment

Occasionally, steroid injection into the affected area may give relief. Intra-articular anesthetic (lidocaine) ankle injection can be used as a differential tool to distinguish between ankle pain and subtalar pain.

Electrotherapeutic modalities also may be helpful.

In ballet dancers, technique assessment is helpful and essential to prevent further pain and injury.

Recovery Phase

Rehabilitation Program

Physical Therapy

Postoperatively, advise posterior splinting for 1 week and a supportive brace and elastic compression stocking. Physical therapy is initiated at 2-3 weeks for strengthening, range of motion, proprioception, and sports-specific rehabilitation.



The goals of pharmacotherapy are to reduce morbidity and to prevent complications.

Drug Category: Nonsteroidal anti-inflammatory drugs

Have analgesic, anti-inflammatory, and antipyretic activities. Mechanism of action is not known but may inhibit cyclooxygenase activity and prostaglandin synthesis. Other mechanisms, such as inhibition of leukotriene synthesis, lysosomal enzyme release, lipoxygenase activity, neutrophil aggregation, and various cell-membrane functions, may exist as well

Drug NameIbuprofen (Motrin, Ibuprin)
DescriptionDOC for patients with mild to moderate pain. Inhibits inflammatory reactions and pain by decreasing prostaglandin synthesis.
Adult Dose400-800 mg PO tid with food
Pediatric Dose10 mg/kg PO tid with food
ContraindicationsDocumented hypersensitivity; peptic ulcer disease, recent GI bleeding or perforation; renal insufficiency; high risk of bleeding
InteractionsCoadministration with aspirin increases risk of inducing serious NSAID-related adverse effects; probenecid may increase concentrations and, possibly, toxicity of NSAIDs; may decrease effect of hydralazine, captopril, and beta-blockers; may decrease diuretic effects of furosemide and thiazides; may increase PT when taking anticoagulants (instruct patients to watch for signs of bleeding); may increase risk of methotrexate toxicity; phenytoin levels may be increased when administered concurrently
PregnancyB - Usually safe but benefits must outweigh the risks.
PrecautionsCategory D in third trimester of pregnancy; caution in congestive heart failure, hypertension, and decreased renal and hepatic function; caution in coagulation abnormalities or during anticoagulant therapy

Drug NameKetoprofen (Actron, Orudis, Oruvail)
DescriptionFor relief of mild to moderate pain and inflammation. Small dosages are initially indicated in small and elderly patients and in those with renal or liver disease. Doses >75 mg do not increase therapeutic effects. Administer high doses with caution and closely observe patient for response.
Adult Dose25-50 mg PO q6-8h prn; not to exceed 300 mg/d
Pediatric Dose3 months to 12 years: 0.1-1 mg/kg PO q6-8h
>12 years: Administer as in adults
ContraindicationsDocumented hypersensitivity
InteractionsCoadministration with aspirin increases risk of inducing serious NSAID-related adverse effects; probenecid may increase concentrations and, possibly, toxicity of NSAIDs; may decrease effect of hydralazine, captopril, and beta-blockers; may decrease diuretic effects of furosemide and thiazides; may increase PT when taking anticoagulants (instruct patients to watch for signs of bleeding); may increase risk of methotrexate toxicity; phenytoin levels may be increased when administered concurrently
PregnancyB - Usually safe but benefits must outweigh the risks.
PrecautionsCategory D in third trimester of pregnancy; caution in congestive heart failure, hypertension, and decreased renal and hepatic function; caution in coagulation abnormalities or during anticoagulant therapy

Drug NameNaproxen (Aleve, Naprosyn, Anaprox, Naprelan)
DescriptionFor relief of mild to moderate pain; inhibits inflammatory reactions and pain by decreasing activity of cyclooxygenase, which results in a decrease of prostaglandin synthesis.
Adult Dose500 mg PO followed by 250 mg q6-8h; not to exceed 1.25 g/d
Pediatric Dose<2 years: Not established
>2 years: 2.5 mg/kg/dose PO; not to exceed 10 mg/kg/d
ContraindicationsDocumented hypersensitivity; peptic ulcer disease; recent GI bleeding or perforation; renal insufficiency
InteractionsCoadministration with aspirin increases risk of inducing serious NSAID-related adverse effects; probenecid may increase concentrations and, possibly, toxicity of NSAIDs; may decrease effect of hydralazine, captopril, and beta-blockers; may decrease diuretic effects of furosemide and thiazides; may increase PT when taking anticoagulants (instruct patients to watch for signs of bleeding); may increase risk of methotrexate toxicity; phenytoin levels may be increased when administered concurrently
PregnancyB - Usually safe but benefits must outweigh the risks.
PrecautionsCategory D in third trimester of pregnancy; acute renal insufficiency, interstitial nephritis, hyperkalemia, hyponatremia, and renal papillary necrosis may occur; patients with preexisting renal disease or compromised renal perfusion risk acute renal failure; leukopenia occurs rarely, is transient, and usually returns to normal during therapy; persistent leukopenia, granulocytopenia, or thrombocytopenia warrants further evaluation and may require discontinuation of drug

Drug NameSulindac (Clinoril)
DescriptionDecreases activity of cyclooxygenase and in turn inhibits prostaglandin synthesis. Results in a decreased formation of inflammatory mediators.
Adult Dose150-200 mg PO bid or 300-400 PO qd; not to exceed 400 mg/d
Pediatric DoseNot established
ContraindicationsDocumented hypersensitivity; hypersensitivity to aspirin, iodides or other NSAIDs; GI bleeding; renal insufficiency
InteractionsCoadministration with aspirin increases risk of inducing serious NSAID-related adverse effects; probenecid may increase concentrations and, possibly, toxicity of NSAIDs; may decrease effect of hydralazine, captopril, and beta-blockers; may decrease diuretic effects of furosemide and thiazides; may increase PT when taking anticoagulants (instruct patients to watch for signs of bleeding); may increase risk of methotrexate toxicity; phenytoin levels may be increased when administered concurrently
PregnancyC - Safety for use during pregnancy has not been established.
PrecautionsCategory D in third trimester of pregnancy; acute renal insufficiency, hyperkalemia, hyponatremia, interstitial nephritis, and renal papillary necrosis may occur; increases risk of acute renal failure in preexisting renal disease or compromised renal perfusion; low white blood cell counts occur rarely, and usually return to normal in ongoing therapy; discontinuation of therapy may be necessary if there is persistent leukopenia, granulocytopenia, or thrombocytopenia; caution in anticoagulation defects or are receiving anticoagulant therapy

Drug NameFlurbiprofen (Ansaid)
DescriptionMay inhibit cyclooxygenase enzyme, which in turn inhibits prostaglandin biosynthesis. These effects may result in analgesic, antipyretic, and anti-inflammatory activities.
Adult Dose200-300 mg/d PO divided bid/qid
Pediatric DoseNot established
ContraindicationsDocumented hypersensitivity
InteractionsCoadministration with aspirin increases risk of inducing serious NSAID-related adverse effects; probenecid may increase concentrations and, possibly, toxicity of NSAIDs; may decrease effect of hydralazine, captopril, and beta-blockers; may decrease diuretic effects of furosemide and thiazides; may increase PT when taking anticoagulants (instruct patients to watch for signs of bleeding); may increase risk of methotrexate toxicity; phenytoin levels may be increased when administered concurrently
PregnancyC - Safety for use during pregnancy has not been established.
PrecautionsCategory D in third trimester of pregnancy; acute renal insufficiency, interstitial nephritis, hyperkalemia, hyponatremia, and renal papillary necrosis may occur; patients with preexisting renal disease or compromised renal perfusion, risk acute renal failure; leukopenia occurs rarely, is transient, and usually returns to normal during therapy; persistent leukopenia, granulocytopenia, or thrombocytopenia warrants further evaluation and may require discontinuation of drug

Drug Category: Opioid analgesics

Pain control is essential to quality patient care. Analgesics ensure patient comfort, promote pulmonary toilet, and have sedating properties, which are beneficial for patients who have sustained trauma or injuries.

Drug NameAcetaminophen and codeine (Tylenol #3)
DescriptionMay inhibit cyclooxygenase enzyme, which in turn inhibits prostaglandin biosynthesis. These effects may result in analgesic, antipyretic, and anti-inflammatory activities.
Adult Dose30-60 mg/dose PO q4-6h (based on codeine content) or 1-2 tab PO q4h; not to exceed 4 g/d of acetaminophen
Pediatric Dose0.5-1 mg/kg/dose PO q4-6h (based on codeine content); 10-15 mg/kg/dose PO (based on acetaminophen content); not to exceed 2.6 g/d of acetaminophen
ContraindicationsDocumented hypersensitivity
InteractionsToxicity of codeine increases with CNS depressants, TCAs, MAOIs, neuromuscular blockers, phenothiazines, and opioid analgesics; rifampin can reduce analgesic effects of acetaminophen; coadministration with barbiturates, carbamazepine, hydantoins, and isoniazid may increase hepatotoxicity of acetaminophen
PregnancyC - Safety for use during pregnancy has not been established.
PrecautionsCaution in patients dependent on opiates, since this substitution may result in acute opiate-withdrawal symptoms; caution in severe renal or hepatic dysfunction; hepatotoxicity with acetaminophen possible in persons with chronic alcoholism following various dose levels; severe or recurrent pain or high or continued fever may indicate a serious illness; acetaminophen is contained in many OTC products and combined use with these products may result in cumulative acetaminophen doses exceeding recommended maximum dose

Drug NameHydrocodone and acetaminophen (Vicodin, Norcet, Lortab)
DescriptionDrug combination indicated for moderate to severe pain.
Adult Dose1-2 tab or cap PO q4-6h prn
Pediatric Dose<12 years: 10-15 mg/kg/dose PO q4-6h (based on acetaminophen content) prn; not to exceed 2.6 g/d acetaminophen
>12 years: 750 mg PO q4h (based on acetaminophen content); not to exceed 10 mg hydrocodone bitartrate per dose or 5 doses/d
ContraindicationsDocumented hypersensitivity; high-altitude cerebral edema or elevated intracranial pressure
InteractionsCoadministration with phenothiazines may decrease analgesic effects; toxicity increases with CNS depressants or TCAs
PregnancyC - Safety for use during pregnancy has not been established.
PrecautionsTablets contain metabisulfite, which may cause hypersensitivity; caution in patients dependent on opiates, since this substitution may result in acute opiate-withdrawal symptoms; caution in severe renal or hepatic dysfunction

Drug NameHydrocodone and ibuprofen (Vicoprofen)
DescriptionDrug combination indicated for short-term (<10 d) relief of moderate to severe acute pain
Adult Dose1-2 tab PO q4-6h prn; not to exceed 5 tab/d
Pediatric DoseNot established
ContraindicationsDocumented hypersensitivity; third trimester of pregnancy
InteractionsCoadministration with aspirin increases risk of inducing serious NSAID-related adverse effects; probenecid may increase concentrations and, possibly, toxicity of NSAIDs; may decrease effect of hydralazine, captopril, and beta-blockers; may decrease diuretic effects of furosemide and thiazides; monitor PT closely (instruct patients to watch for signs of bleeding); may increase risk of methotrexate toxicity; phenytoin levels may be increased when administered concurrently
PregnancyC - Safety for use during pregnancy has not been established.
PrecautionsCaution in impaired renal function, peptic ulcer disease, impaired thyroid function, asthma, hypertension, edema, heart failure, increased intracranial pressure, and erosive gastritis; duration of action may increase in elderly persons

Drug NamePropoxyphene and acetaminophen (Darvocet-N 100, Propacet, Wygesic)
DescriptionDrug combination indicated for mild to moderate pain.
Adult Dose1-2 tab PO q4h prn; not to exceed 600 mg/d
Pediatric DoseNot established
ContraindicationsDocumented hypersensitivity
InteractionsMay increase serum concentrations of MAOIs, TCAs, carbamazepine, phenobarbital, and warfarin
PregnancyC - Safety for use during pregnancy has not been established.
PrecautionsCaution in patients dependent on opiates, substitution may result in acute opiate withdrawal symptoms; caution in severe renal or hepatic dysfunction



Return to Play

Patients are allowed to return to sports or activities as tolerated in approximately 4-6 weeks, depending on the completion of physical therapy goals. Somewhat longer rehabilitation may be required with syndesmotic impingement.

Prevention

In sports such as ballet, correct technique can help prevent injury.

Education

For excellent patient education resources, visit eMedicine's Foot, Ankle, Knee, and Hip Center, Sports Injury Center, and Sprains and Strains Center. Also, see eMedicine's patient education articles Ankle Sprain and Sprains and Strains.



Special Concerns

  • According to multiple follow-up studies, excellent and good postoperative results can be expected for approximately 84% of patients (Ferkle, 1991; Liu, 1994; Ogilvie-Harris, 1997).



  • Brukner P, Khan K. Pain in the Achilles Region. In: Clinical Sports Medicine. 2nd. New York: McGraw-Hill; 2000:chapter 28.
  • Ferkel RD. Ankle and foot injuries. In: Fu FH, Stone DA, eds. Sports Injuries. Baltimore, Md: Lippincott Williams & Wilkins; 1994.
  • Ferkel RD. Arthroscopy of the Foot and Ankle. 7th ed. St Louis, Mo: Mosby; 1999:1257-1297.
  • Ferkel RD. Soft tissue pathology of the ankle. In: McGinty JB, Caspari RB, Jackson RW, Poehling GG, eds. Operative Arthroscopy. 2nd ed. Philadelphia, Pa: Lippincott Raven; 1996:1141-1155.
  • Ferkel RD, Karzel RP, Del Pizzo W, Friedman MJ, Fischer SP. Arthroscopic treatment of anterolateral impingement of the ankle. Am J Sports Med. Sep-Oct 1991;19(5):440-6. [Medline].
  • Glassman F, Wolin I, Sideman S, Levinthal DH. Internal Derangement of the Talofibular Component of the Ankle. Surg Gynecl Obstet. 1950;91:193-200.
  • Henderson I, La Valette D. Ankle impingement: combined anterior and posterior impingement syndrome of the ankle. Foot Ankle Int. Sep 2004;25(9):632-8. [Medline].
  • Jackson DW, Ashley RL, Powell JW. Ankle sprains in young athletes. Relation of severity and disability. Clin Orthop Relat Res. Jun 1974;101(01):201-15. [Medline].
  • Liu SH, Raskin A, Osti L, Baker C, Jacobson K, Finerman G, et al. Arthroscopic treatment of anterolateral ankle impingement. Arthroscopy. Apr 1994;10(2):215-8. [Medline].
  • Maquirriain J. Posterior ankle impingement syndrome. J Am Acad Orthop Surg. Oct 2005;13(6):365-71. [Medline].
  • Ogilvie-Harris DJ, Gilbart MK, Chorney K. Chronic pain following ankle sprains in athletes: the role of arthroscopic surgery. Arthroscopy. Oct 1997;13(5):564-74. [Medline].
  • Pfeffer G, ed. Chronic Ankle Pain in the Athlete. AAOS Monograph Series. ed. Rosemont, Ill: American Academy of Orthopaedic Surgeons; 2000:57-67.

Ankle Impingement Syndrome excerpt

Article Last Updated: Jul 5, 2006